Exela Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EXELA PHARMA, and what generic alternatives to EXELA PHARMA drugs are available?
EXELA PHARMA has twenty-three approved drugs.
There are seventeen US patents protecting EXELA PHARMA drugs.
Summary for Exela Pharma
| US Patents: | 17 |
| Tradenames: | 20 |
| Ingredients: | 20 |
| NDAs: | 23 |
| Patent Litigation for Exela Pharma: | See patent lawsuits for Exela Pharma |
Drugs and US Patents for Exela Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 205643-001 | Nov 1, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Exela Pharma | MIDAZOLAM IN 0.8% SODIUM CHLORIDE | midazolam | SOLUTION;INTRAVENOUS | 215868-001 | Jul 20, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Exela Pharma | GANZYK-RTU | ganciclovir | SOLUTION;INTRAVENOUS | 209347-001 | Feb 17, 2017 | RX | Yes | Yes | 9,486,530 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Exela Pharma | CAFFEINE CITRATE | caffeine citrate | SOLUTION;ORAL | 077304-001 | Sep 21, 2006 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
